November 7, 2022
Via: PharmaphorumArtificial Intelligence (AI) and deep learning have already transformed several aspects of small molecule drug design. Recent advances in the area are now also impacting more complex tasks, such as design and optimisation of antibodies. As a result, 2022 saw […]
September 19, 2022
Via: GENThe World Health Organization (WHO) Guideline Development Group recommended that patients with COVID-19 not receive the antibody drugs sotrovimab and casirivimab-imdevimab. The Group’s recommendation replaces previous conditional recommendations “Rapid Recommendations: A living WHO guideline on drugs for Covid-19,” published in […]
Clinical Trials, Research and Development
June 21, 2021
Via: Biopharma DiveThe first half of 2021 was historic for biotech. The Food and Drug Administration cleared the first new Alzheimer’s drug in nearly two decades, a controversial decision with far-reaching consequences. Multiple effective coronavirus vaccines and antibody drugs helped bring the […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
